Aya Matsui

Kanazawa, 9208640, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Brain insulin signaling restores deficits in striatal dopamine release in overweight male mice with preexisting low D2-receptor expression.

Brain insulin signaling restores deficits in striatal dopamine release in overweight male mice with preexisting low D2-receptor expression.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

CD157+ vascular endothelial stem cells represent a conserved subpopulation with an angiogenic gene expression profile.

CD157+ vascular endothelial stem cells represent a conserved subpopulation with an angiogenic gene expression profile.

Journal: Stem cell reports
Published: September 29, 2025

Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma.

Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma.

Journal: Research square
Published: May 05, 2025

Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma.

Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma.

Journal: Nature communications
Published: April 11, 2025

A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment.

A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment.

Journal: Surgical oncology
Published: March 18, 2025

Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma.

Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma.

Journal: bioRxiv : the preprint server for biology
Published: March 17, 2025

HIFU induces reprogramming of the tumor immune microenvironment in a pancreatic cancer mouse model.

HIFU induces reprogramming of the tumor immune microenvironment in a pancreatic cancer mouse model.

Journal: Medical molecular morphology
Published: November 13, 2024

Combination CXCR4 and PD-1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma.

Combination CXCR4 and PD-1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma.

Journal: Cancer immunology research
Published: April 06, 2024

Fluorescence Lifetime Imaging Enables In Vivo Quantification of PD-L1 Expression and Intertumoral Heterogeneity.

Fluorescence Lifetime Imaging Enables In Vivo Quantification of PD-L1 Expression and Intertumoral Heterogeneity.

Journal: Cancer research
Published: March 14, 2024

In vivo quantification of programmed death-ligand-1 expression heterogeneity in tumors using fluorescence lifetime imaging.

In vivo quantification of programmed death-ligand-1 expression heterogeneity in tumors using fluorescence lifetime imaging.

Journal: Research square
Published: November 14, 2023

Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma models.

Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma models.

Journal: bioRxiv : the preprint server for biology
Published: November 14, 2023

A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment.

A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment.

Journal: Research square
Published: August 14, 2023
Showing 1-12 of 27

Last Updated: 09/26/2026